- Rheumatologie-App Injektionstechnik
- Neue Studien
- Kongress Highlights
- EULAR 2018
- EULAR 2017
- EULAR 2016
- EULAR 2015
- EULAR 2014
- ACR 2018
- ACR 2017
- ACR 2015
- ACR 2014
- Rheuma Top 2018
- Rheuma Top 2017
- Rheuma Top 2015
- Rheuma Top 2014
- Bilddatenbank
- RheumaTool
- SlideSet RA
- SlideSetSpA
- SonoTool
- FOCUS «Der Fuss»
- FOCUS «Kinderrheumatologie»
- EisenPaket
- LupusPaket
- OsteoPaket
- Publikationen
- Literaturservice
- Richtlinien
- Schmerzpaket
- Immunotalk
EULAR 2017 | Daily Highlights
ATTENUATION OF FLUORINE-18-FLUORODEOXYGLUCOSE UPTAKE IN LARGE VESSEL GIANT CELL ARTERITIS AFTER SHORT-TERM HIGH-DOSE STEROID TREATMENT - A DIAGNOSTIC WINDOW OF OPPORTUNITY
Abstract: Op0285Authors: B. D. Nielsen1,*, L. C. Gormsen2, I. T. Hansen1, K. K. Keller1, P. Therkildsen1, E.-M. Hauge1
1Department of Rheumatology, 2Department of Nuclear Medicine and PET centre, Aarhus University Hospital, Århus, Denmark
Background
Fluorine-18-fluorodeoxyglucose (FDG) PET/CT is increasingly used to diagnose large vessel GCA (LV-GCA) due to its excellent diagnostic accuracy[1]. However, PET/CT is not always readily available, which may compel the clinician to 1) either delay steroid treatment at the risk of GCA related complications, or 2) initiate treatment at the expense of diagnostic sensitivity of the FDG PET/CT study.
Objectives
To evaluate if FDG PET/CT can accurately diagnose LV-GCA after 3 or 10 days of high-dose steroid treatment.
Methods
Twenty-four treatment-naïve patients (16 women) with a mean age of 69 (range 57-84) years with FDG PET/CT (PET0) proven LV-GCA repeated FDG PET/CT after either 3 (PET3, n=10) or 10 days (PET10, n=14) of treatment with oral prednisolone 60 mg daily. Prior to treatment, clinical examination and laboratory tests were performed to confirm GCA and exclude differential diagnoses. A temporal artery biopsy (TAB) was performed in all patients.
Two experienced nuclear medicine physicians blinded to clinical data reviewed the FDG PET/CT images. LV-GCA was suspected if increased FDG uptake in the wall of the aorta and/or supra-aortic branches was observed. A semi-quantitative approach was applied (a.m. Meller) in which FDG uptake was graded on a 5-point scale (0; no uptake, 1; ≤ blood pool, 2; > blood pool, ≤ liver, 3; ≥ liver, 4; ≥ 2xliver). A score ≥3 was considered consistent with vasculitis[2]. Vascular composite scores (CS) was calculated summarizing grades from assessed vascular regions; Aortic: Aorta ascendens, aorta descendens and aortic arch; aortic branches: Vertebral, carotic and subclavian/axillary artery.
Results
Mean CRP and ESR were 72 (95% CI: 55; 94) mg/l and 81 (95% CI: 72; 90) mm/h, respectively. ACR criteria for GCA was fulfilled by 18/24 patients and 17/21 had a positive TAB. Mean number of prednisolone doses before the post-treatment FDG PET/CT were 3.1 (SD 0.3) (PET3) and 10.3 (SD 0.7) (PET10).
Vascular CS in aorta did not decrease at PET3 (9 (IQR 9-9) vs. 9 (IQR 6-9)) whereas a significant decrease was observed in aortic branches at PET3 (6.5 (IQR 6-8) vs 5.5 (IQR 5-7), p<e;0.01) and both vascular domains at PET10 (Aortic; 9 (IQR 9-9) vs. 5.5 (IQR 3-6), aortic branches; 7 (IQR 7-8) vs 5 (IQR 4-6)). Although, FDG uptake decreased in aortic branches after 3 days, LV-GCA could still be accurately diagnosed in 10/10 patients. By contrast, LV-GCA could only be diagnosed in 5/14 patients after 10 days (PET0 vs. PET10, p<e;0.01).
At day 10, VAS global was significantly higher in patients with positive PET10 compared to patients with negative PET10 (5.2 (95% CI 3.6; 7.0) vs. 2.7 (95% CI 1.2; 4.2), p<e;0.05). No clinically significant differences in baseline phenotypical presentation, CRP or PET CS were found between patients with positive and negative PET10, respectively.
Interrater reliability of visual FDG-uptake-grading was substantial (agreement 90%, Cohens weighted kappa 0.67).
Conclusions
In LV-GCA, high-dose steroid treatment for three or ten days differentially attenuates the regional uptake of FDG but diagnostic accuracy remains within the first three days.
References
1. Puppo et al. BioMed research international 2014
2. Stellingwerff MD et al. Medicine 2015
Acknowledgements
Assesment of PET scans by Stine Kramer and Tronds Bogsrud is mostly appreciated.
Disclosure of Interest:
None declared
DOI: 10.1136/annrheumdis-2017-eular.5788
Comment:
Bei 24 Patientinnen (17 Frauen) mit PET/CT diagnostizierter Grossgefässvaskulitis wurde in 10 Fällen nach 3 Tagen und in 14 Fällen nach 10 Tagen die Untersuchung wiederholt. Alle Patientinnen waren bei Erstuntersuchung ohne Steroide und erhielten danach 60mg pro Tag. Eine Temporalisbiopsie wurde bei allen durchgeführt. Die Signale wurden wie folgt bewertet: 0 = kein Uptake; 1 = Blutpool; 2 = ≥ Blutpool, ≤ Leber; 3 = ≥Leber 4 = ≥ 2x Leber. Ein Signal ≥ 3 wurde als Vaskulitis interpretiert. Die Patienten erfüllten die klassischen Charakteristika einer RZA (CRP, BSR, Alter, Histologie, ACR Kriterien). Das Signal nahm bereits nach 3 Tagen (= 3 Dosen Steroide) deutlich ab, die Diagnose war aber zu diesem Zeitpunkt noch zu stellen. Nach 10 Tagen wären 9 RZA verpasst worden. Als Fazit kann man festhalten, dass nicht nur die MR-Angiographie und die Doppleruntersuchung sondern auch die PET/CT nach einigen Tagen Steroidmedikation unzuverlässig wird. Dies steht im Kontrast zur Histologie der Temporalisbiopsie, die bis 4 Wochen nach Steroidbeginn noch diagnostisch bleibt. Es empfiehlt sich also, die bildgebende Diagnostik rasch und vor Therapiebeginn durchzuführen und die Biopsie umgehend, wenn möglich innert 14 Tagen zu planen.

Prof. Dr. Peter Villiger
Inselspital Bern
< zurück